CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Idec (NASDAQ: BIIB) today announced that IVS Associates, Inc., the independent Inspector of Election for Biogen Idec’s 2008 Annual Meeting of Stockholders, has certified that stockholders elected all four of the Board's nominees – Cecil B. Pickett, Ph.D., Lynn Schenk, J.D., Phillip A. Sharp, Ph.D., and Stelios Papadopoulos, Ph.D. – to the Biogen Idec Board of Directors by a substantial majority of the shares voted.
